Table 1.
Tumor tissues investigated
| Patient | Tumor | mRNA expression (AU) | |||||||
| No | Sex | Age | Stage | Lymph node status | Metastasis status | Grade | E2F3 | ID4 | DEK |
| 3 | m | 75 | pT3b | N0 | M0 | G2 | 5.59 | 0.48 | 4.88 |
| 6 | m | 76 | pT3b | pN2 | M0 | G3 | 10.37 | 0.36 | 1.37 |
| 12 | m | 70 | pT3a | N0 | M0 | G3 | 1.73 | 0.04 | 1.99 |
| 28 | m | 72 | pT3b | N0 | M0 | G3 | 3.73 | 0.24 | 2.27 |
| 41 | f | 54 | pTa | Nx | Mx | G2 | 11.69 | 0.49 | 3.29 |
| 47 | m | 76 | pT3b | N0 | M0 | G3 | 3.75 | 0.19 | 1.84 |
| 52 | f | 87 | pT3b | N0 | M0 | G3 | 2.86 | 0.25 | 1.43 |
| 55 | m | 83 | pT4a | N1 | M0 | G3 | 1.25 | 0.18 | 0.52 |
| 61 | m | 75 | pT3b | N0 | M0 | G3 | 1.98 | 0.12 | 1.48 |
| 62 | f | 78 | pT3b | N0 | M0 | G2 | 1.60 | 0.54 | 0.72 |
| 64 | m | 74 | pT3b | N2 | M0 | G3 | 3.34 | 0.11 | 1.26 |
| 67 | f | 94 | >pT2 | Nx | Mx | G3 | 4.38 | 0.33 | 1.50 |
| 69 | m | 77 | pT3b | N0 | M0 | G3 | 2.17 | 0.14 | 1.19 |
| 104 | m | 61 | pT1 | N0 | M0 | G2 | 1.49 | 0.24 | 0.72 |
| 105 | m | 83 | pTa | Nx | M0 | G2 | 3.80 | 0.27 | 1.88 |
| 109 | m | 68 | pT4a | N0 | M0 | G3 | 2.14 | 0.23 | 0.30 |
| 111 | m | 81 | pT3b | N0 | M0 | G2-3 | 2.24 | 0.52 | 0.61 |
| 115 | m | 74 | pT3a | N2 | M0 | G3 | 1.74 | 0.12 | 0.84 |
| 120 | m | 66 | pT2 | N0 | Mx | G2 | 3.12 | 0.15 | 0.66 |
| 150 | f | 78 | pT3a | N2 | M0 | G3 | 0.54 | 0.20 | 0.86 |
| 168 | m | 64 | pT3a | N2 | M0 | G3 | 1.68 | 0.12 | 1.42 |
| 170 | f | 63 | pT2 | N0 | M0 | G2 | 0.58 | 0.08 | 0.27 |
| 172 | m | 72 | pT3a | N0 | M0 | G3 | 1.73 | 0.13 | 0.85 |
| 205 | f | 65 | pT2 | N0 | M0 | G2 | 0.36 | 0.10 | 0.17 |
| 212 | m | 73 | pT2a | N1 | M0 | G2 | 0.62 | 0.16 | 0.79 |
| 224 | m | 65 | pT2a | N0 | M0 | G2 | 4.29 | 3.39 | 1.87 |
| 231 | m | 95 | >pT2 | Nx | M0 | G2 | 13.04 | 1.11 | 1.59 |
| 246 | m | 67 | pT4a | N2 | M0 | G3 | 3.07 | 0.27 | 1.29 |